Distinguishing mitochondrial DNA and NUMT sequences amplified with the precision ID mtDNA whole genome panel.


Journal

Mitochondrion
ISSN: 1872-8278
Titre abrégé: Mitochondrion
Pays: Netherlands
ID NLM: 100968751

Informations de publication

Date de publication:
11 2020
Historique:
received: 11 03 2020
revised: 31 08 2020
accepted: 04 09 2020
pubmed: 20 9 2020
medline: 5 5 2021
entrez: 19 9 2020
Statut: ppublish

Résumé

Nuclear mitochondrial DNA segments (NUMTs) are generated via transfer of portions of the mitochondrial genome into the nuclear genome. Given their common origin, there is the possibility that both the mitochondrial and NUMT segments may co-amplify using the same set of primers. Thus, analysis of the variation of the mitochondrial genome must take into account this co-amplification of mitochondrial and NUMT sequences. The study herein builds on data from the study by Strobl et al. (Strobl et al., 2019), in which multiple point heteroplasmies were called with an "N" to prevent labeling NUMT sequences mimicking mitochondrial heteroplasmy and being interpreted as true mitochondrial in origin sequence variants. Each of these point heteroplasmies was studied in greater detail, both molecularly and bioinformatically, to determine whether NUMT or true mitochondrial DNA variation was present. The bioinformatic and molecular tools available to help distinguish between NUMT and mitochondrial DNA and the effect of NUMT sequences on interpretation were discussed.

Identifiants

pubmed: 32949792
pii: S1567-7249(20)30179-3
doi: 10.1016/j.mito.2020.09.001
pii:
doi:

Substances chimiques

DNA, Mitochondrial 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

122-133

Informations de copyright

Copyright © 2020 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Auteurs

Jennifer Churchill Cihlar (JC)

Center for Human Identification, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, TX 76107, USA; Department of Microbiology, Immunology, and Genetics, University of North Texas Health. Science Center, 3500 Camp Bowie Boulevard, Fort Worth, TX 76107, USA. Electronic address: Jennifer.Cihlar@unthsc.edu.

Christina Strobl (C)

Institute of Legal Medicine, Medical University of Innsbruck, Innsbruck, Austria.

Robert Lagacé (R)

Human Identification Group, Thermo Fisher Scientific, San Francisco, CA, USA.

Melissa Muenzler (M)

Center for Human Identification, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, TX 76107, USA.

Walther Parson (W)

Institute of Legal Medicine, Medical University of Innsbruck, Innsbruck, Austria; Forensic Science Program, The Pennsylvania State University, University Park, PA, USA.

Bruce Budowle (B)

Center for Human Identification, University of North Texas Health Science Center, 3500 Camp Bowie Boulevard, Fort Worth, TX 76107, USA; Department of Microbiology, Immunology, and Genetics, University of North Texas Health. Science Center, 3500 Camp Bowie Boulevard, Fort Worth, TX 76107, USA.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH